Clinical Trial Update: E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating E-CEL UVEC as adjunct cell therapy for anal fistula is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Fistula

Drugs mentioned

• E-CEL UVEC

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Anal Fistula | Phase 1 | Status: RECRUITING